Statistics for The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII
Total visits
| views | |
|---|---|
| The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII | 175 |
Total visits per month
| views | |
|---|---|
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
File Visits
| views | |
|---|---|
| Poster FVIIaR_Porto2000.pdf(legacy) | 372 |
| Poster FVIIaR_Porto2000.pdf | 4 |
| ap_173.pdf(legacy) | 2 |
| Poster ARTRITE SÉPTICA NA HEMOFILIA.pdf(legacy) | 1 |
| Acta Med Port 1994_7_475.pdf(legacy) | 1 |
Top country views
| views | |
|---|---|
| United States | 95 |
| Russia | 19 |
| Germany | 14 |
| China | 13 |
| France | 7 |
| Portugal | 6 |
| Canada | 4 |
| Netherlands | 4 |
| Poland | 4 |
| United Kingdom | 3 |
| Turkey | 2 |
| Ghana | 1 |
| Hong Kong SAR China | 1 |
| Italy | 1 |
| Ukraine | 1 |